loading
Scinai Immunotherapeutics Ltd Adr stock is traded at $1.47, with a volume of 197.11K. It is up +0.68% in the last 24 hours and down -40.96% over the past month. Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
See More
Previous Close:
$1.46
Open:
$1.47
24h Volume:
197.11K
Relative Volume:
0.16
Market Cap:
$1.47M
Revenue:
-
Net Income/Loss:
$-9.29M
P/E Ratio:
-0.2827
EPS:
-5.2
Net Cash Flow:
$-9.42M
1W Performance:
-28.64%
1M Performance:
-40.96%
6M Performance:
-59.04%
1Y Performance:
-64.66%
1-Day Range:
Value
$1.40
$1.5501
1-Week Range:
Value
$1.40
$3.48
52-Week Range:
Value
$1.40
$6.18

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Name
Name
Scinai Immunotherapeutics Ltd Adr
Name
Phone
972-8-9302529
Name
Address
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCNI's Discussions on Twitter

Compare SCNI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SCNI
Scinai Immunotherapeutics Ltd Adr
1.47 1.46M 0 -9.29M -9.42M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News

pulisher
Jul 29, 2025

Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier - Barchart.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment By Investing.com - Investing.com Canada

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

ICICI Bank Ltd. ADR (IBN) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Benzinga

Jul 29, 2025
pulisher
Jun 19, 2025

Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 19, 2025
pulisher
Jun 04, 2025

Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks

Jun 02, 2025
pulisher
May 09, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart.com

May 09, 2025
pulisher
May 08, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports $4.8M Net Gain in 2024, Driven by Loan-to-Equity Conversion - Barchart.com

May 08, 2025
pulisher
May 01, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders - Barchart.com

May 01, 2025
pulisher
Apr 01, 2025

Military Breakthrough: BrainChip and Raytheon Land $1.8M Air Force Deal for Next-Gen Radar - Stock Titan

Apr 01, 2025
pulisher
Mar 05, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Enters $10M Standby Equity Purchase Agreement - Barchart

Mar 05, 2025
pulisher
Feb 07, 2025

Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Evaluating the Annual Growth - The News Heater

Feb 07, 2025
pulisher
Sep 26, 2024

Bayerische Motoren Werke ADR (OP: BMWYY - FinancialContent

Sep 26, 2024
pulisher
Jun 18, 2024

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga

Jun 18, 2024
pulisher
Jun 07, 2024

Scinai regains Nasdaq compliance, eyes EIB loan conversion - Investing.com

Jun 07, 2024

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):